Literature DB >> 1645643

Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group.

J P Matts1, H Buchwald, L L Fitch, C T Campos, R L Varco, G S Campbell, M B Pearce, A E Yellin, W A Edmiston, R D Smink.   

Abstract

The entry characteristics of patients in the Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized, controlled, clinical trial, are described in this article. The primary objective addressed by POSCH was whether lowering total plasma cholesterol by partial ileal bypass surgery results in a reduction in mortality and morbidity in post-myocardial infarction patients. Between 1975 and 1983, 838 patients between the ages of 30 and 64 years were randomized into POSCH. The mean age at entry was 51 years, and 91% of the patients were men. The mean time between myocardial infarction and entry was 2.2 years. The mean baseline total plasma cholesterol was 251 mg/dl, with a mean LDL-cholesterol of 179 mg/dl and a mean HDL-cholesterol of 40 mg/dl. Significant disease (greater than or equal to 50% occlusion) of one or more major coronary arteries was found in 91% of the patients. In addition to a description of the POSCH patient population at entry, comparisons of the POSCH patient population to populations of participants in other lipid-lowering trials are presented to provide a perspective on how POSCH relates to these trials.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645643     DOI: 10.1016/0197-2456(91)90028-k

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  2 in total

Review 1.  Gastrointestinal surgery: cardiovascular risk reduction and improved long-term survival in patients with obesity and diabetes.

Authors:  Ted D Adams; Lance E Davidson; Sheldon E Litwin; Steven C Hunt
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

2.  Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.

Authors:  H Buchwald; C T Campos; J P Matts; L L Fitch; J M Long; R L Varco
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.